Recently, Mdg1/ERdj4 has been described to prevent maturation of aggregated amyloid beta peptides, which are associated with Alzheimer’s disease (Hoshino et al. 2007). Here, DNAJB9 is linked to early-onset autosomal dominant Alzheimer disease.